Search results for "PROTECTION"

showing 10 items of 1623 documents

Past and present work practices of European interventional cardiologists in the context of radiation protection of the eye lens—results of the EURALO…

2018

International audience; This paper investigates over five decades of work practices in interventional cardiology, with an emphasis on radiation protection. The analysis is based on data from more than 400 cardiologists from various European countries recruited for a EURALOC study and collected in the period from 2014 to 2016. Information on the types of procedures performed and their annual mean number, fluoroscopy time, access site choice, x-ray units and radiation protection means used was collected using an occupational questionnaire. Based on the specific European data, changes in each parameter have been analysed over decades, while country-specific data analysis has allowed us to dete…

medicine.medical_specialty[SDV]Life Sciences [q-bio]030204 cardiovascular system & hematologyRadiology InterventionalTotal occlusion030218 nuclear medicine & medical imaging03 medical and health sciencesDose limit0302 clinical medicineCardiologistsRadiation Protectionaccess routesAccess routesCardiac proceduresLens CrystallineMedicineFluoroscopyHumansMedical physicsEye lensWaste Management and Disposalmedicine.diagnostic_testInterventional cardiologybusiness.industryinterventional cardiologyPublic Health Environmental and Occupational HealthHemodynamicsWorkloadGeneral Medicine3. Good healthfluoroscopywork practice of interventional cardiologistsEuropeFluoroscopyWork practice of interventional cardiologistsRadiation protectionbusinessElectrophysiologic Techniques Cardiacradiation protection
researchProduct

Influence of Propofol on Neuronal Damage and Apoptotic Factors after Incomplete Cerebral Ischemia and Reperfusion in Rats

2004

Background Propofol reduces neuronal damage from cerebral ischemia when investigated for less than 8 postischemic days. This study investigates the long-term effects of propofol on neuronal damage and apoptosis-related proteins after cerebral ischemia and reperfusion. Methods Male Sprague-Dawley rats were randomly assigned as follows: group 1 (n = 32, control): fentanyl and nitrous oxide-oxygen; group 2 (n = 32, propofol): propofol and oxygen-air. Ischemia (45 min) was induced by carotid artery occlusion and hemorrhagic hypotension. Pericranial temperature and arterial blood gases were maintained constant. After 1, 3, 7, and 28 postischemic days, brains were removed, frozen, and sliced. Hi…

medicine.medical_specialtybusiness.industryIschemiaHippocampal formationmedicine.diseaseNeuroprotectionFentanylBrain ischemiaAnesthesiology and Pain MedicineEndocrinologyApoptosisAnesthesiaInternal medicinemedicineArterial bloodPropofolbusinessmedicine.drugAnesthesiology
researchProduct

Effet neuroprotecteur de l’accident ischémique transitoire

2011

Transient ischemic attack (TIA) is a well-recognized risk factor of ischemic stroke. Hence, 7 to 25% of ischemic stroke patients have a history of TIA, and the risk of ischemic stroke after TIA is about 15% at 3 months. However, epidemiological studies have demonstrated that among patients with ischemic stroke, those with a history of TIA have better functional and vital prognoses. This protective effect is particularly found in case of recent and short TIA, and in case of non-lacunar ischemic stroke. Hence, TIA can induce endogenous neuroprotection by the ischemic tolerance phenomenon that decreases the neurodegeneration usually caused by a severe cerebral ischemia in a non-preconditioned …

medicine.medical_specialtybusiness.industryNeurodegenerationIschemiaGeneral Medicine030204 cardiovascular system & hematologymedicine.diseaseNeuroprotectionnervous system diseases3. Good healthSurgery03 medical and health sciences0302 clinical medicineInternal medicineparasitic diseasesIschemic strokeCardiologyMedicinecardiovascular diseasesRisk factorbusiness030217 neurology & neurosurgeryLa Presse Médicale
researchProduct

Safety and efficacy of endovascular treatment for carotid artery stenoses using proximal protection systems : 30-day follow-up

2017

Introduction. Although surgical endarterectomy remains the treatment of choice for carotid artery stenosis, carotid artery stenting (CAS) with use of proximal protection systems (PPS) plays an important role as alternative treatment modality, especially in high risk patients. This study was aimed at the assessment of safety of CAS with use of the PPS and also at identification of risk factors associated with this procedure. Material and methods. This was a post hoc analysis, with 30-day follow-up. We analysed results of treatment of 94 patients who underwent 97 CAS with PPS, 47 such procedures in asymptomatic, and 50 in symptomatic individuals. Results. There were 0 strokes during 30-day fo…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentTransient ischaemic attacksmedicine.diseaseAsymptomaticSurgeryStenosismedicine.anatomical_structurestentsmedicine.arteryInternal medicinePost-hoc analysisCardiologyproximal protection systemsMedicineMyocardial infarctionInternal carotid arterymedicine.symptomCardiology and Cardiovascular Medicinebusinesscarotid angioplastyArteryEndarterectomy
researchProduct

Increased Connexin 43 Expression as a Potential Mediator of the Neuroprotective Activity of the Corticotropin-Releasing Hormone

2009

CRH is a major central stress mediator, but also a potent neuroprotective effector. The mechanisms by which CRH mediates its neuroprotective actions are largely unknown. Here, we describe that the gap junction molecule connexin43 (Cx43) mediates neuroprotective effects of CRH toward experimentally induced oxidative stress. An enhanced gap junction communication has been reported to contribute to neuroprotection after neurotoxic insults. We show that CRH treatment up-regulates Cx43 expression and gap junctional communication in a CRH receptor-dependent manner in IMR32 neuroblastoma cells, primary astrocytes, and organotypic hippocampal slice cultures. MAPKs and protein kinase A-cAMP response…

medicine.medical_specialtyendocrine systemCorticotropin-Releasing HormoneMAP Kinase Signaling SystemCarbenoxoloneConnexinBiologyNeuroprotectionModels BiologicalArticleRats Sprague-DawleyCorticotropin-releasing hormoneMiceEndocrinologyMediatorInternal medicineCell Line Tumormedicinepolycyclic compoundsAnimalsHumansProtein kinase AMolecular BiologyGap junctionBrainGap JunctionsGeneral MedicineCell biologyRatsEndocrinologyNeuroprotective Agentsnervous systemGene Expression RegulationConnexin 43cardiovascular systemSignal transductionhormones hormone substitutes and hormone antagonistsmedicine.drugSignal Transduction
researchProduct

Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?

2015

Current therapy directed at delaying the progression of diabetic nephropathy includes intensive glycemic and optimal blood pressure control, renin angiotensin-aldosterone system blockade and multifactorial intervention. However, the renal protection provided by these therapeutic modalities is incomplete. There is a scarcity of studies analysing the nephroprotective effect of antihyperglycaemic drugs beyond their glucose lowering effect and improved glycaemic control on the prevention and progression of diabetic nephropathy. This article analyzes the exisiting data about older and newer drugs as well as the mechanisms associated with hypoglycemic drugs, apart from their well known blood gluc…

medicine.medical_specialtylcsh:MedicineReviewPharmacologyalbuminuriaDiabetic nephropathyDDP4 inhibitorsDiabetes mellitusantihyperglycemic drugsSGLT2 inhibitionRenin–angiotensin systemDiabetic nephropathiesmedicineIntensive care medicineGlycemicnephroprotectionKidneyDiabetisdiabetic chronic kidney diseasebusiness.industrydiabetic nephropathylcsh:RDiabetesGeneral MedicineNefropaties diabètiquesmedicine.diseaseBlockadeClinical trialmedicine.anatomical_structurediabetes mellitusAlbuminuriaglucagon-like peptide agonistsmedicine.symptombusiness
researchProduct

From structural biochemistry to expression profiling: Neuroprotective activities of estrogen

2005

Abstract Estrogens are neuromodulatory and neuroprotective hormones. Chemically, estrogens are steroid compounds and unfold most of their activities through the activation of nuclear receptors that bind to specific target genes and control their transcription. Two subtypes of estrogen receptors are known (estrogen receptor α and estrogen receptor β) and they are expressed throughout the body including the CNS and in particular the brain. We employed large scale DNA-chip-analysis to display the gene expression pattern differentially regulated by both estrogen receptor subtypes in human neuronal cells. We identified different gene families regulated by estrogen receptors that complement the k…

medicine.medical_specialtymedicine.drug_classModels NeurologicalEstrogen receptorBiologyNeuroprotectionAntioxidantsCell Line TumorInternal medicinemedicineHumansEstrogen receptor betaPELP-1EstradiolGene Expression ProfilingGeneral NeuroscienceBrainEstrogensCell biologyGene expression profilingNeuroprotective AgentsEndocrinologyReceptors EstrogenNuclear receptorEstrogenFemaleNervous System Diseaseshormones hormone substitutes and hormone antagonistsHormoneNeuroscience
researchProduct

Shockwave intravascular lithoplasty for the treatment of calcified carotid artery stenosis: A very early single-center experience

2020

Endovascular treatment of calcified carotid disease represents one of the main challenges for the interventionalists. Plaque calcium load is one of the most important factors affecting the risk of procedural complications. A new tool called Shockwave intravascular lithotripsy (S-IVL; Shockwave Medical, Inc.) has been recently approved for the treatment of heavily calcified coronary and lower limb arteries but minimal data exist about the treatment of carotid arteries. We report our early experience of carotid stenting using S-IVL. We report two cases of symptomatic patients with severely calcified carotid artery diseases who were turned down for vascular surgeries. The first case was succes…

medicine.medical_specialtymedicine.medical_treatmentContext (language use)030204 cardiovascular system & hematologyLithotripsyBalloonembolic protection device03 medical and health sciences0302 clinical medicineAngioplastyMedicinecalcified plaque; carotid stroke; embolic protection deviceRadiology Nuclear Medicine and imagingcardiovascular diseases030212 general & internal medicinecarotid strokebusiness.industryStentGeneral Medicinemedicine.diseaseDebulkingStenosiscalcified plaque carotid stroke embolic protection device Aged Carotid Stenosis Embolic Protection Devices Female Humans Male Stents Treatment Outcome Vascular Calcification Angioplasty Balloon LithotripsyRadiologycalcified plaqueCarotid stentingCardiology and Cardiovascular Medicinebusiness
researchProduct

Anesthetics and Cerebral Protection in Patients Undergoing Carotid Endarterectomy

2015

EREBRAL ISCHEMIA/HYPOXIA may occur in a vari-ety of perioperative circumstances. The main pathophy-siologic aspects involved in cerebral ischemia/reperfusion arecaused by adenosine triphosphate (ATP) consumption, theexcitotoxic actions of glutamate, changes in ionic homeostasis,and formation of free radicals (Fig 1). Outcomes from suchevents range from subclinical neurocognitive deficits to cata-strophic neurologic morbidity or death.

medicine.medical_specialtymedicine.medical_treatmentIschemiaCarotid endarterectomyAnesthesia GeneralNeuroprotectionSevofluraneBrain Ischemia03 medical and health sciences0302 clinical medicine030202 anesthesiologyInternal medicinemedicineAnimalsHumansIschemic PreconditioningSubclinical infectionEndarterectomy Carotidbusiness.industryGlutamate receptorPerioperativeHypoxia (medical)medicine.disease3. Good healthNeuroprotective AgentsAnesthesiology and Pain MedicineAnesthesiaAnesthetics InhalationCardiologymedicine.symptomCardiology and Cardiovascular Medicinebusiness030217 neurology & neurosurgerymedicine.drugJournal of Cardiothoracic and Vascular Anesthesia
researchProduct

Patient- and lesion-tailored algorithm of endovascular treatment for arterial occlusive disease of extracranial arteries supplying the brain: safety …

2017

Introduction: Although surgical endarterectomy remains the treatment of choice for carotid artery stenosis, stenting plays an important role as an alternative treatment modality, especially in high-risk patients. The actual safety profile associated with stenting procedures is probably better than that reported by randomized controlled trials. Aim : To assess the safety of stent implantations in extracranial arteries supplying the brain, and also to identify risk factors associated with this procedure. Material and methods: This was a post hoc analysis, with 30-day follow-up. We analyzed the results of treatment of 372 patients who underwent 408 procedures, 197 such procedures in asymptomat…

medicine.medical_specialtymedicine.medical_treatmentlcsh:Medicine030204 cardiovascular system & hematologyAsymptomaticCoronary artery diseaseLesion03 medical and health sciences0302 clinical medicinePost-hoc analysismedicinecardiovascular diseasesEndarterectomyOriginal Papercarotid artery stentingbusiness.industrylcsh:RStentmedicine.diseaseSurgeryStenosismedicine.anatomical_structureproximal protection systemdistal protection systemmedicine.symptomCardiology and Cardiovascular Medicinebusiness030217 neurology & neurosurgeryArteryAdvances in Interventional Cardiology
researchProduct